Red cell and hemorheological changes in multiple sclerosis

Pathology
|January 1, 1987
PubMed

Insights

Multiple sclerosis (MS) patients show altered blood viscosity and erythrocyte filtration. These findings suggest potential therapeutic targets for improving MS prognosis.

Area of Science:

  • Hematology
  • Neuroimmunology
  • Biophysics

Background:

  • Multiple sclerosis (MS) is a chronic neurological disease.
  • Understanding blood rheology in MS is crucial for disease management.

Purpose of the Study:

  • To investigate blood rheology differences in multiple sclerosis (MS) patients compared to healthy controls.
  • To identify potential biomarkers and therapeutic targets in MS.

Main Methods:

  • Whole blood viscosity and erythrocyte filtration were measured.
  • Scanning electron microscopy and erythrocyte membrane analysis were performed.
  • Leukocyte counts were compared between MS patients and controls.

Main Results:

  • MS patients exhibited higher whole blood viscosity and lower erythrocyte filtration rates.
  • Significant differences in erythrocyte morphology and membrane composition were observed in MS.
  • Elevated leukocyte counts were found in MS patients.

Conclusions:

  • Identifiable and potentially correctable abnormalities in blood rheology exist in MS.
  • These findings offer hope for inhibiting MS progression and improving patient prognosis.

Related Concept Videos

Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...